Chapter 73 Drug Therapy of Rheumatoid Arthritis Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Drugs for Rheumatoid Arthritis Rheumatoid arthritis (RA) Autoimmune inflammatory disorder Treatment Relieve symptoms Maintain joint function Minimize systemic involvement Delay progression of disease Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 2 Classes of Antiarthritic Drugs NSAIDs DMARDs Nonsteroidal anti-inflammatory drugs Disease-modifying antirheumatic drugs Glucocorticoids Adrenal corticosteroids Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 3 Drug Selection for Rheumatoid Arthritis Protocol Start with NSAIDs If symptoms persist, add DMARDs Glucocorticoids may be added until DMARDs take effect Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 4 DMARDs I: Major Nonbiologic DMARDs Methotrexate Sulfasalazine Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 5 Methotrexate Most rapid-acting DMARD Therapeutic effect: 3 to 6 weeks Adverse effects Hepatic fibrosis Bone marrow suppression GI ulceration Pneumonitis Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 6 Sulfasalazine Used to treat inflammatory bowel disease (IBD); now used for RA as well Anti-inflammatory and immunomodulatory actions Can slow progression of joint deterioration GI side effects may be intolerable Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 7 Other DMARDs I: Major Nonbiologic DMARDs Leflunomid (Arava) Hydroxychloroquine (Plaquenil) Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 8 DMARDs II: Major Biologic DMARDs Tumor necrosis factor inhibitors Suppress immune function Pose risk of serious infection Work by neutralizing tumor necrosis factor (TNF) • Etanercept (Enbrel) • Infliximab (Remicade) • Adalimumab (Humira) Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 9 Etanercept New DMARD Use Inactivates TNF Moderate to severe RA Adverse effects Infection (may be serious) Injection-site reactions Tuberculosis Heart failure Cancer Other adverse effects Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. 10